Ipilimumab vs Phenazopyridine Hydrochloride
Ipilimumab vs Phenazopyridine Hydrochloride: Overview
This comparison examines the pharmacological differences between Ipilimumab and Phenazopyridine Hydrochloride.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Ipilimumab β Antibody; Phenazopyridine Hydrochloride β Small molecule.